Seija Olivier, NP
Adult Health · Brownstown Twp, MINPI 1164976908
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,225 and has fallen 93.2% since, to $83 in 2025.
Across 159 payments — averaging $20.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$431
- Takeda Pharmaceuticals U.S.A., Inc.$215
- Seagen Inc.$208
- Amgen$186
- Karyopharm Therapeutics Inc.$164
- Genentech USA, Inc.$158
- plus $2K from 36 others
What the payments were for
- Food & beverage$3,20396%
- Education$1194%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 22 | $431 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $215 |
| Seagen Inc. | 7 | $208 |
| Amgen | 12 | $186 |
| Karyopharm Therapeutics Inc. | 7 | $164 |
| Genentech USA, Inc. | 8 | $158 |
| Astellas Pharma US Inc | 7 | $156 |
| Bristol Myers Squibb | 6 | $154 |
| Eisai Inc. | 7 | $154 |
| Sanofi | 7 | $148 |
| AstraZeneca | 6 | $111 |
| Merck | 5 | $94 |
| AMAG Pharmaceuticals, Inc. | 4 | $79 |
| AVEO Pharmaceuticals, Inc. | 4 | $70 |
| Daiichi Sankyo Inc. | 3 | $68 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $66 |
| EMD Serono, Inc. | 3 | $64 |
| Sobi, Inc | 3 | $60 |
| Dova Pharmaceuticals | 3 | $59 |
| Taiho Oncology, Inc. | 2 | $51 |
| Gilead | 3 | $50 |
| AbbVie | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $43 |
| Pharmaessentia USA Corporation | 2 | $43 |
| Recordati_rare_diseases_inc. | 2 | $39 |
| Johnson & Johnson | 2 | $39 |
| Pharmacosmos Therapeutics Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Boston Scientific | 2 | $32 |
| Tersera Therapeutics LLC | 1 | $27 |
| Beigene USA, Inc. | 1 | $26 |
| ADC Therapeutics America, Inc. | 1 | $25 |
| Bayer | 1 | $22 |
| Pfizer | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $19 |
| Rigel Pharmaceuticals, Inc. | 1 | $19 |
| Exelixis Inc. | 1 | $19 |
| Stemline Therapeutics Inc. | 1 | $19 |
| Servier Pharmaceuticals LLC | 1 | $17 |
| Foundation Medicine, Inc. | 1 | $17 |
| GSK | 1 | $14 |
How this compares
$3,322 in reported general payments places this provider in the 85th percentile of 527 adult health providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 11 | $449 |
Paid to pharmacies, not to this prescriber.
Other adult health in Brownstown Twp
- Jacqueline BrewerSterling Heights$138K
- Linda Morris McCoyGrand Rapids$59K
- Sarita RaoCanton$51K
- Susanne QuallichAnn Arbor$42K
- Nancy BermanSouthfield$39K
- Michelle MillerQuincy$24K
- Deniene KingAnn Arbor$14K
- Adama JohnsonEastpointe$14K
- Bridget BonelloWyandotte$13K
- Mary KaiserKalamazoo$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.